New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 9, 2019 - Teva launched AB-rated generic versions of Genentech’s Tarceva (erlotinib) 100 mg and 150 mg tablets, and Mylan launched AB-rated generic versions of Tarceva 25 mg, 100 mg, and 150 mg tablets.
Download PDF
Return to publications
